Dr. Cesar V. Borlongan, University of South Florida and a team of researchers have successfully identified DJ-1 as a potential therapeutic target for treating stroke. They used our hNP1TM Human Neural Progenitors to confirm the neuroprotective properties of the DJ-1 protein: Yuji Kaneko, Hideki Shojo, Jack Burns, Meaghan Staples, Naoki Tajiri, Cesar V. Borlongan, DJ-1 ameliorates ischemic cell death in vitro possibly via mitochondrial pathway, Neurobiology of Disease, Available online 21 September 2013, ISSN 0969-9961, http://dx.doi.org/10.1016/j.nbd.2013.09.007.
•DJ-1 translocation was assayed in oxygen–glucose deprived human neural progenitor cells.
•Immunofluorescent microscopy and ELISA were used to measure DJ-1 translocation.
•DJ-1 translocated preferentially into polarized mitochondria.
•DJ-1 translocation is associated with the preservation of functional mitochondria.
•DJ-1 exhibits antioxidative stress effects following ischemic stroke.
I will continue to post updates on Research success with our Cell Based Assay Solutions.